Bio-Techne Corp. | Income Statement

Fiscal year is July-June. All values USD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
357,763.00
452,246.00
499,023.00
563,003.00
642,993.00
Cost of Goods Sold (COGS) incl. D&A
112,452.00
161,669.00
180,664.00
209,790.00
232,500.00
Gross Income
245,311.00
290,577.00
318,359.00
353,213.00
410,493.00
SG&A Expense
82,461.00
138,054.00
165,005.00
206,840.00
249,510.00
EBIT
162,850.00
152,523.00
153,354.00
-
160,983.00
Unusual Expense
3,100.00
5,500.00
2,761.00
25,789.00
24,805.00
Non Operating Income/Expense
1,042.00
251.00
1,613.00
1,566.00
447.00
Interest Expense
-
1,544.00
1,748.00
7,361.00
10,188.00
Pretax Income
161,392.00
154,162.00
147,481.00
111,961.00
125,952.00
Income Tax
50,444.00
46,427.00
43,005.00
35,875.00
198.00
Consolidated Net Income
110,948.00
107,735.00
104,476.00
76,021.00
126,042.00
Net Income
110,948.00
107,735.00
104,476.00
76,021.00
126,042.00
Net Income After Extraordinaries
110,948.00
107,735.00
104,476.00
76,021.00
126,042.00
Net Income Available to Common
110,948.00
107,735.00
104,476.00
76,021.00
126,042.00
EPS (Basic)
3.00
2.89
2.80
2.03
3.31
Basic Shares Outstanding
36,890.00
37,096.00
37,194.00
37,313.00
37,476.00
EPS (Diluted)
3.00
2.89
2.80
2.03
3.31
Diluted Shares Outstanding
37,005.00
37,231.00
37,326.00
37,500.00
38,055.00
EBITDA
182,025.00
189,749.00
196,118.00
206,409.00
225,446.00
Non-Operating Interest Income
2,684.00
634.00
249.00
304.00
409.00
Equity in Affiliates (Pretax)
-
8,300.00
-
-
-
Other After Tax Income (Expense)
-
-
-
65.00
108.00

About Bio-Techne

View Profile
Address
614 McKinley Place NE
Minneapolis Minnesota 55413
United States
Employees -
Website http://www.bio-techne.com
Updated 07/08/2019
Bio-Techne Corp. engages in the development, manufacture and sale of biotechnology reagents and instruments for the research and clinical diagnostic markets. It operates through the following segments: Biotechnology, Protein Platforms, Diagnostics, and Corporate. The Biotechnology segment supplies specialized proteins, such as cytokines and growth factors, immunoassays, antibodies and related reagents, as well as in situ hybridization, media and other cell culture products and reagents to the biotechnology research community.